Skip to main content
. 2011 Jun 10;11:233. doi: 10.1186/1471-2407-11-233

Table 1.

Demographic and clinicopathologic characteristics of study cohort

BPH Cancer
N = 114 N = 105
Median Age (range, y) 60 (30-86) 60 (41-79)
Race
 White 73 (64) 72 (69)
 African American 30 (26) 17 (16)
 Other 11 (10) 16 (15)
Median Serum PSA (ng/ml) 0.9+1.8 5.7 ± 5.1
Clinical Stage
T1c n/a 74 (70%)
T2a n/a 26 (25%)
T2b n/a 1 (1%)
T2c n/a 2 (2%)
T3a/b n/a 1 (1%)
T2aNxM1 n/a 1 (1%)
Gleason Score
6 n/a 68 (65%)
7 n/a 23 (22%)
>7 n/a 14 (13%)